US Broker Ratings

GeneDx Holdings Corp. (WGS) Stock Analysis: A Diagnostic Powerhouse with Robust Revenue Growth

GeneDx Holdings Corp. (WGS), a key player in the healthcare sector, has been making waves in the diagnostics and research industry. With a market capitalization of..

Artivion, Inc. (AORT) Stock Analysis: A Look at Its 12.89% Potential Upside in the Healthcare Sector

Artivion, Inc. (NASDAQ: AORT) has recently caught the attention of investors, thanks to its promising 12.89% potential upside. The Georgia-based medical device company has been making..

LifeStance Health Group, Inc. (LFST) Stock Analysis: Exploring a 30.97% Potential Upside in the Healthcare Sector

LifeStance Health Group, Inc. (NASDAQ: LFST) is making significant strides in the healthcare sector, focusing on mental health services across the United States. With a market..

Astrana Health Inc. (ASTH) Investor Outlook: Exploring an 81.97% Upside Potential

Astrana Health Inc. (NASDAQ: ASTH) has emerged as an intriguing prospect in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization..

Ultragenyx Pharmaceutical Inc. (RARE) Stock Analysis: Uncovering a 149.69% Potential Upside in Biotech

Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) stands as a beacon in the biotechnology sector, renowned for its focus on developing therapies for rare and ultra-rare genetic diseases...

ANI Pharmaceuticals, Inc. (ANIP) Stock Analysis: Exploring a 35.68% Upside with Robust Revenue Growth

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) presents an intriguing opportunity for investors in the healthcare sector, particularly within the specialty and generic drug manufacturing industry. With a..

Immunocore Holdings plc (IMCR) Stock Analysis: A 65.13% Potential Upside Beckons Investors

Immunocore Holdings plc (NASDAQ: IMCR) stands at the forefront of biotechnology innovation, specializing in pioneering immunotherapies for the treatment of oncology, infectious, and autoimmune diseases. Headquartered..

BGM Group Ltd. (BGM): Investor Outlook Amidst Uncertain Valuation and Performance Metrics

BGM Group Ltd. (BGM), a healthcare sector player in the drug manufacturing industry, has caught the attention of investors despite its recent financial challenges. Based in..

NovoCure Limited (NVCR) Stock Analysis: Exploring a 98.95% Potential Upside

For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with its significant potential upside of 98.95%, as indicated by..

Ardent Health, Inc. (ARDT) Stock Analysis: Navigating a 57% Potential Upside with Strong Buy Ratings

Ardent Health, Inc. (ARDT), a prominent player in the U.S. healthcare sector, focuses on delivering comprehensive medical services through its extensive network of hospitals and clinics...

Bausch Health Companies Inc. (BHC) Stock Analysis: Unveiling a 17% Potential Upside Amid a Challenging Market

Bausch Health Companies Inc. (NYSE: BHC), a prominent player in the healthcare sector with a specific focus on drug manufacturing, presents an intriguing opportunity for investors..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Powerhouse with 47.3% Potential Upside

Liquidia Corporation (NASDAQ: LQDA) has emerged as a noteworthy contender in the biotechnology sector, capturing investor attention with its remarkable revenue growth and substantial market cap..

Brookdale Senior Living Inc. (BKD) Stock Analysis: Exploring Growth Potential Amidst Volatility

Brookdale Senior Living Inc. (NYSE: BKD) stands as a prominent player within the medical care facilities industry, residing under the broad umbrella of the healthcare sector...

QuidelOrtho Corporation (QDEL) Stock Analysis: Exploring a 41.71% Upside Potential in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL) is an intriguing player in the healthcare sector, particularly within the medical devices industry. With a current market capitalization of $1.81 billion,..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring a 21% Potential Upside in the Biotech Sector

Twist Bioscience Corporation (NASDAQ: TWST) stands at the forefront of innovation in the healthcare sector, specifically within the diagnostics and research industry. Based in South San..

Vera Therapeutics (VERA): Investor Outlook Reveals 112.89% Potential Upside in Biotech Breakthrough

Vera Therapeutics, Inc. (NASDAQ: VERA) is making waves in the biotechnology sector with its promising pipeline of immunological treatments, attracting significant attention from investors. Headquartered in..

Vericel Corporation (VCEL) Stock Analysis: Exploring a 43% Potential Upside in Biotech

Vericel Corporation (NASDAQ: VCEL) presents a unique opportunity in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $1.97 billion, Vericel has..

Surgery Partners, Inc. (SGRY) Stock Analysis: Unpacking the 57.93% Potential Upside for Savvy Investors

Surgery Partners, Inc. (NASDAQ: SGRY), a prominent player in the healthcare sector specializing in medical care facilities, presents an intriguing opportunity for investors seeking exposure to..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Evaluating an 83.73% Potential Upside

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the health information services sector, stands out as a compelling investment opportunity with a potential upside of..

ICU Medical, Inc. (ICUI): Investor Outlook Reveals 21.74% Potential Upside and Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI), a key player in the healthcare sector specializing in medical instruments and supplies, has captured investor attention with a promising potential..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds